Celularity Inc.
CELU
$2.02
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -7.88% | -49.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.88% | -49.80% | |||
| Cost of Revenue | -25.52% | 47.50% | |||
| Gross Profit | 179.35% | -93.72% | |||
| SG&A Expenses | -26.34% | -11.41% | |||
| Depreciation & Amortization | -12.63% | 1.09% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.05% | -1.42% | |||
| Operating Income | 19.01% | -51.29% | |||
| Income Before Tax | 5.90% | -24.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.90% | -24.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.90% | -24.15% | |||
| EBIT | 19.01% | -51.29% | |||
| EBITDA | 21.05% | -62.16% | |||
| EPS Basic | 14.22% | -21.62% | |||
| Normalized Basic EPS | 12.05% | -64.01% | |||
| EPS Diluted | 14.22% | -21.62% | |||
| Normalized Diluted EPS | 12.05% | -64.01% | |||
| Average Basic Shares Outstanding | 9.69% | 2.08% | |||
| Average Diluted Shares Outstanding | 9.69% | 2.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||